NCT07226986
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07226986
Title A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | AUS

Facility Status City State Zip Country Details
Rio Grande Urology RECRUITING El Paso Texas 79912 United States Details
Utah Intermountain Medical Center RECRUITING Murray Utah 84107 United States Details
Novartis Investigative Site RECRUITING Malvern Victoria 3144 Australia Details
Novartis Investigative Site RECRUITING Melbourne Victoria 3004 Australia Details
Novartis Investigative Site RECRUITING Murdoch Western Australia 6150 Australia Details
Novartis Investigative Site RECRUITING Clermont-Ferrand 63011 France Details
Novartis Investigative Site RECRUITING Nantes 44093 France Details
Novartis Investigative Site RECRUITING Essen 45147 Germany Details
Novartis Investigative Site RECRUITING Sapporo Hokkaido 060-8648 Japan Details
Novartis Investigative Site RECRUITING Granada Andalusia 18014 Spain Details
Novartis Investigative Site RECRUITING Barcelona 08036 Spain Details
Novartis Investigative Site RECRUITING Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field